Correlation Between Teva Pharma and Durect

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Teva Pharma and Durect at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharma and Durect into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Teva Pharma Industries and Durect, you can compare the effects of market volatilities on Teva Pharma and Durect and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharma with a short position of Durect. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharma and Durect.

Diversification Opportunities for Teva Pharma and Durect

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Teva and Durect is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharma Industries and Durect in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Durect and Teva Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharma Industries are associated (or correlated) with Durect. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Durect has no effect on the direction of Teva Pharma i.e., Teva Pharma and Durect go up and down completely randomly.

Pair Corralation between Teva Pharma and Durect

Given the investment horizon of 90 days Teva Pharma Industries is expected to generate 0.75 times more return on investment than Durect. However, Teva Pharma Industries is 1.33 times less risky than Durect. It trades about 0.22 of its potential returns per unit of risk. Durect is currently generating about 0.07 per unit of risk. If you would invest  1,703  in Teva Pharma Industries on September 21, 2024 and sell it today you would earn a total of  506.00  from holding Teva Pharma Industries or generate 29.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Teva Pharma Industries  vs.  Durect

 Performance 
       Timeline  
Teva Pharma Industries 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharma Industries are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Teva Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Durect 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Durect has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Teva Pharma and Durect Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Teva Pharma and Durect

The main advantage of trading using opposite Teva Pharma and Durect positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharma position performs unexpectedly, Durect can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Durect will offset losses from the drop in Durect's long position.
The idea behind Teva Pharma Industries and Durect pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios